KNOMATIC Trademark

Trademark Overview


On Tuesday, August 27, 2024, a trademark application was filed for KNOMATIC with the United States Patent and Trademark Office. The USPTO has given the KNOMATIC trademark a serial number of 98720113. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, August 27, 2024. This trademark is owned by Moma Therapeutics, Inc.. The KNOMATIC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune disease, and other diseases that involve the functionality of highly dynamic proteins; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders

drug discovery services; pharmaceutical research services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development; technical consulting in the field of pharmaceutical studies; technical research in the field of pharmaceutical studies; research and development services of new pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; providing medical research information in the field of pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research in the field of bioinformatics; biological and bio-technology analysis services; DNA sequencing technology research; research in the field of DNA mutation; DNA analysis services for scientific research purposes; providing genetic science information; scientific research consulting in the field of pharm...
knomatic

General Information


Serial Number98720113
Word MarkKNOMATIC
Filing DateTuesday, August 27, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Serviceschemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune disease, and other diseases that involve the functionality of highly dynamic proteins; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders
Goods and Servicesdrug discovery services; pharmaceutical research services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development; technical consulting in the field of pharmaceutical studies; technical research in the field of pharmaceutical studies; research and development services of new pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; providing medical research information in the field of pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research in the field of bioinformatics; biological and bio-technology analysis services; DNA sequencing technology research; research in the field of DNA mutation; DNA analysis services for scientific research purposes; providing genetic science information; scientific research consulting in the field of pharmaceuticals and drug discovery; medical and scientific research in the field of proteomics; scientific research for medical purposes in the field of proteomics; structural and functional analysis of genomes; software as a service (SAAS) services in the nature of a drug discovery platform that utilizes structural analysis, hit finding techniques and computational analysis and targets diseases related to highly dynamic proteins; software as a service (SAAS) services in the nature of drug design and structure activity relationships; software as a service (SAAS) services featuring software for drug discovery, pharmaceutical research and development, and medical research and development; ยท software as a service (SAAS) services in the nature of DNA encoded library (DEL) screening; software as a service (SAAS) services in the nature of genetic sequencing software; software as a service (SAAS) services featuring software using artificial intelligence (AI) for drug discovery, pharmaceutical research and development, and medical research and development; software as a service (SAAS) services featuring software using machine learning for drug discovery, pharmaceutical research and development, and medical research and development; drug discovery software platform as a service particularly targeting diseases related to highly dynamic proteins by utilizing structural analysis, hit finding techniques and computational analysis; software as a service (SAAS) services for use in developing and prioritizing lead compounds for drug development; software as a service (SAAS) services in the field of biochemistry; software as a service (SAAS) services in the field of biophysics; software as a service (SAAS) services in the field of structural biology; software as a service (SAAS) services in the field of chemistry; software as a service (SAAS) services in the nature of a knowledge based drug discovery platform; software as a service (SAAS) services in the nature of data analysis software for use in drug discovery; software as a service (SAAS) services in the nature of drug discovery software utilizing hit finding techniques.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 27, 2024
Primary Code005
First Use Anywhere DateMonday, August 19, 2024
First Use In Commerce DateMonday, August 19, 2024

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 27, 2024
Primary Code042
First Use Anywhere DateMonday, August 19, 2024
First Use In Commerce DateMonday, August 19, 2024

Trademark Owner History


Party NameMoma Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events


Event DateEvent Description
Tuesday, August 27, 2024NEW APPLICATION ENTERED